Clinical Trials Browser

Phase 2/3 × Neoplasm, Residual × Lymphoid × Clear all

NCT00795756 2014-10-22

Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia

Phase 2/3 Completed

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma